| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $2.79 In Line |
| EPS GAAP Actual | $2.79 In Line |
| Revenue Actual | $0.505396B |
| Revenue Surprise | Beat by $505.396M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.28333 |
| EPS GAAP Estimate | $1.28333 |
| Revenue Estimate | $0.501866B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 9.36 | 21.75 | 9.1562 | 9.55281 | 1 |
| Mar 2030 | 9.36 | 21.75 | 9.06828 | 9.58237 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.38 | 1.38 | 0.505396B | 15.75% | 505.4M |
| FQ2 2025 (Jun 2025) | 1.75 | 1.75 | 0.504067B | 16.01% | 504.07M |
| FQ1 2025 (Mar 2025) | 1.23 | 1.23 | 0.453749B | 14.39% | 453.75M |
| FQ4 2024 (Dec 2024) | 2.46 | 2.46 | 0.60817B | 14.43% | 608.17M |
| FQ3 2024 (Sep 2024) | 0.96 | 0.96 | 0.425799B | 9.89% | 425.8M |
| FQ2 2024 (Jun 2024) | 1.28 | 1.28 | 0.423386B | -0.54% | 423.39M |
| FQ1 2024 (Mar 2024) | 0.97 | 0.97 | 0.388459B | 100% | 388.46M |
| FQ4 2023 (Dec 2023) | 1.84 | 1.84 | 0.520399B | 1.12% | 520.4M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
1.28333
Consensus Revenue Estimates
0.501866B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 7 |
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 6 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 6 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 6 |
| FQ1 2027 (Mar 2027) | 1.64 | -- | 1.61419 | 1.65189 | 4 |
| FQ4 2026 (Dec 2026) | 2.88499 | -- | 2.84051 | 2.94257 | 6 |
| FQ3 2026 (Sep 2026) | 1.35333 | -1.97 | 1.33203 | 1.36314 | 4 |
| FQ2 2026 (Jun 2026) | 1.75333 | 0.19 | 1.72574 | 1.76604 | 4 |
| FQ1 2026 (Mar 2026) | 1.28333 | 4.16 | 1.23073 | 1.35223 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0.69B | -- | 0.67B | 0.71B | 5 |
| FQ4 2027 (Dec 2027) | 0.91B | -- | 0.87B | 0.93B | 5 |
| FQ3 2027 (Sep 2027) | 0.65B | -- | 0.63B | 0.66B | 4 |
| FQ2 2027 (Jun 2027) | 0.65B | -- | 0.62B | 0.66B | 8 |
| FQ1 2027 (Mar 2027) | 0.59B | -- | 0.58B | 0.59B | 7 |
| FQ4 2026 (Dec 2026) | 0.77B | -- | 0.76B | 0.78B | 3 |
| FQ3 2026 (Sep 2026) | 0.55B | 8.04 | 0.54B | 0.55B | 7 |
| FQ2 2026 (Jun 2026) | 0.55B | 8.41 | 0.54B | 0.55B | 4 |
| FQ1 2026 (Mar 2026) | 0.5B | 9.59 | 0.49B | 0.52B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.38 | 1.38 | 100% | |
| FQ2 2025 (Jun 2025) | 1.75 | 1.75 | 100% | |
| FQ1 2025 (Mar 2025) | 1.23 | 1.23 | 100% | |
| FQ4 2024 (Dec 2024) | 2.46 | 2.46 | 100% | |
| FQ3 2024 (Sep 2024) | 0.96 | 0.96 | 100% | |
| FQ2 2024 (Jun 2024) | 1.28 | 1.28 | 100% | |
| FQ1 2024 (Mar 2024) | 0.97 | 0.97 | 100% | |
| FQ4 2023 (Dec 2023) | 1.84 | 1.84 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.51B | $505.4M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.5B | $504.07M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.45B | $453.75M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.61B | $608.17M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.43B | $425.8M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.42B | $423.39M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.39B | $388.46M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.52B | $520.4M | 100% |